Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
Yıldırım, Hasan Çağrı, Mutlu, Emel, Chalabiyev, Elvin, Özen, Miraç, Keskinkılıç, Merve, Ön, Sercan, Çelebi, Abdussamet, Dursun, Bengü, Acar, Ömer, Kahraman, Seda, Aykan, Musa Barış, Kaman, Ömür, Doğan, Akif, Erdoğan, Atike Pınar, Melisa Celayir, Özde, Günenç, Damla, Güven, Deniz Can, Vedat Bayoğlu, İbrahim, Yavuzşen, Tuğba, Hacıbekiroğlu, İlhan, İnanç, Mevlüde, Kılıçkap, Saadettin, Yalçın, Şuayib, Aksoy, Sercan
Published in Breast (Edinburgh) (01.12.2022)
Published in Breast (Edinburgh) (01.12.2022)
Get full text
Journal Article
The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas
MUTLU, Emel, BOZKURT, Oktay, İNANÇ, Mevlüde, OZKAN, Metin, FIRAT, Sedat Tarık, COŞAR, Ramazan, BUĞDAY, İrfan, CENGİZ, Muhammet, DİŞLİ, Ahmet Kürşad, ESER, Murat
Published in Hitit medical journal (26.02.2024)
Published in Hitit medical journal (26.02.2024)
Get full text
Journal Article
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
Akyildiz, Arif, Guven, Deniz Can, Ozluk, Ahmet Anil, Ismayilov, Rashad, Mutlu, Emel, Unal, Olcun Umit, Yildiz, Ibrahim, Iriagac, Yakup, Turhal, Serdar, Akbas, Sinem, Bayram, Ertugrul, Telli, Tugba Akin, Turkoz, Fatma Paksoy, Ozcelik, Melike, Erciyestepe, Mert, Selvi, Oguzhan, Gulbagci, Burcu, Erturk, Ismail, Isleyen, Zehra Sucuoglu, Kahraman, Seda, Akdag, Mutianur Ozkorkmaz, Hamitoglu, Buket, Unek, Ilkay Tugba, Unal, Caglar, Hacibekiroglu, İlhan, Arslan, Cagatay, Azizy, Abdulmunir, Helvaci, Kaan, Demirci, Umut, Dizdar, Omer, Basaran, Mert, Goker, Erdem, Sendur, Mehmet Ali, Yalcin, Suayib
Published in Medicine (Baltimore) (10.11.2023)
Published in Medicine (Baltimore) (10.11.2023)
Get full text
Journal Article
Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events
Onur, İlknur Deliktaş, Mutlu, Emel, Sertesen, Elif, Önder, Tuğba, Duran, Ayşe Ocak, İnanç, Mevlüde
Published in Immunotherapy (01.03.2024)
Published in Immunotherapy (01.03.2024)
Get more information
Journal Article
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
Yıldırım, Hasan Çağrı, Kutlu, Yasin, Mutlu, Emel, Aykan, Musa Barış, Korkmaz, Mustafa, Yalçın, Selim, Şakalar, Teoman, Celayir, Özde Melisa, Kayıkçıoğlu, Erkan, Aslan, Ferit, Hafızoğlu, Emre, Altıntaş, Yunus Emre, Keskinkılıç, Merve, Chalabiyev, Elvin, Çelebi, Abdussamet, Dursun, Bengü, Kapar, Caner, Özen, Miraç, Acar, Ömer, Dülgar, Özgecan, Kut, Engin, Biter, Sedat, Kus, Fatih, Almuradova, Elvina, Erdoğan, Atike Pınar, Saray, Seray, Güven, Deniz Can, Şimşek, Eda Tanrıkulu, Üskent, Necdet, Kemal, Yasemin, Çakar, Burcu, Açıkgöz, Özgür, Kılıçkap, Saadettin, Aksoy, Sercan
Published in International journal of clinical oncology (01.03.2024)
Published in International journal of clinical oncology (01.03.2024)
Get full text
Journal Article
Is cytogenetic damage a biomarker for the risk of malignancy development in renal transplantation patients?
Mutlu,Emel, Ünal,Aydın, Kiraz,Aslıhan, Taşdemir,Arzu, Kökenek Ünal,Tuba Dilay, Koçyiğit,İsmail, Sipahioğlu,Murat Hayri, Tokgöz,Bülent
Published in Hipokrat Tıp Dergisi (01.01.2022)
Published in Hipokrat Tıp Dergisi (01.01.2022)
Get full text
Journal Article